
Azathioprine
Azathioprine is an older immunosuppressant approved for kidney transplant rejection prevention and rheumatoid arthritis. Its boxed warning is malignancy, and it can cause serious drops in blood counts, especially with low TPMT or NUDT15 activity. The critical interaction is with allopurinol (and febuxostat); live probiotic supplements are rated high.
Prescription medication: not a dietary supplement
This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.
Quick decision guide
May help most
Kidney transplant recipients and adults with active rheumatoid arthritis whose specialist prescribes azathioprine
Common dosing range
Set by your prescriber by body weight: usually 3 to 5 mg/kg daily at the start after kidney transplant and 1 to 3 mg/kg for maintenance, or about 1 mg/kg (50 to 100 mg) daily to start for rheumatoid arthritis, up to 2.5 mg/kg
When to expect effects
Several weeks in rheumatoid arthritis, usually 6 to 8; the label says an adequate trial is at least 12 weeks
Watch out for
Boxed warning: higher risk of cancer, including lymphoma. Can cause severe low blood counts, especially with TPMT or NUDT15 deficiency or with allopurinol; needs regular blood counts
What is it
Azathioprine is a prescription immunosuppressant taken as tablets. It is sold as generic azathioprine, as Imuran (50 mg tablets) and as Azasan (75 mg and 100 mg tablets). The label approves it as an add-on treatment to prevent rejection after a kidney transplant and to reduce the signs and symptoms of active rheumatoid arthritis. For rheumatoid arthritis, the label says aspirin, NSAIDs and low-dose steroids may be continued, but that use with other disease-modifying antirheumatic drugs (DMARDs) has not been studied and cannot be recommended; your prescriber decides what fits your treatment. Doctors also use it off-label for other immune conditions, such as Crohn's disease, which the label says it has not been established for. It needs regular blood tests while you take it.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
rheumatoid arthritis Limited Evidence | Moderate to large on joint tenderness, with more side-effect withdrawals | Adults with active rheumatoid arthritis for whom a specialist judges other options unsuitable | Measured at 6 months |
keeping Crohn's disease in remission (off-label) Limited Evidence | Small to moderate; about 11 more people in 100 stayed in remission | Adults with Crohn's disease in remission whose gastroenterologist recommends a thiopurine | Measured over 6 to 18 months |
rheumatoid arthritis
- Effect
- Moderate to large on joint tenderness, with more side-effect withdrawals
- Best fit
- Adults with active rheumatoid arthritis for whom a specialist judges other options unsuitable
- Time
- Measured at 6 months
keeping Crohn's disease in remission (off-label)
- Effect
- Small to moderate; about 11 more people in 100 stayed in remission
- Best fit
- Adults with Crohn's disease in remission whose gastroenterologist recommends a thiopurine
- Time
- Measured over 6 to 18 months
Evidence for 2 uses
AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.
rheumatoid arthritis
Disease adjunctA Cochrane review pooled 3 older placebo-controlled trials with 81 patients with rheumatoid arthritis. Azathioprine improved tender joint scores at 6 months (standardized mean difference -0.98), but withdrawals because of side effects were higher (odds ratio 4.56). Effects on long-term function and joint damage on x-ray could not be assessed. The reviewers found toxicity higher than with other disease-modifying drugs and no evidence to recommend azathioprine over them.
Bottom line: Azathioprine reduced joint tenderness in a few small, old trials, at the cost of more side effects.
keeping Crohn's disease in remission (off-label)
Disease adjunctThis is an off-label use; the label says safety and efficacy in Crohn's disease have not been established. A Cochrane review pooled 6 trials with 489 adults whose Crohn's disease was quiet. Over 6 to 18 months, 73% on azathioprine (1.0 to 2.5 mg/kg a day) stayed in remission versus 62% on placebo (risk ratio 1.19; 9 people treated for one extra person to benefit). GRADE certainty was low. Azathioprine raised the risk of serious adverse events (risk ratio 2.45) and of withdrawal for side effects.
Bottom line: Low-certainty evidence suggests azathioprine helps keep Crohn's disease in remission, an off-label use limited by side effects.
How it works
How to take it
What to track
Bottom line: Your prescriber sets the dose by weight and blood counts; keep every blood test, and never combine it with a gout medicine without your prescriber's plan.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Boxed warning (malignancy): long-term immunosuppression with azathioprine raises the risk of cancer, including post-transplant lymphoma and hepatosplenic T-cell lymphoma (HSTCL) in people with inflammatory bowel disease. HSTCL cases were very aggressive and fatal, mostly in adolescent and young adult males. Skin cancer risk is also higher, so sun exposure should be limited.
Severe low blood counts and bone marrow suppression, which can be delayed. People with TPMT or NUDT15 deficiency are at higher risk of severe, life-threatening myelotoxicity, and deaths from pancytopenia have occurred with absent TPMT activity. About 1 in 300 people of European or African ancestry have little or no TPMT activity; among people of East Asian ancestry, about 2% have two non-working NUDT15 copies.
Serious infections, including reactivation of latent infections and progressive multifocal leukoencephalopathy (PML), sometimes fatal.
Liver injury, mostly in transplant patients, including rare but life-threatening hepatic veno-occlusive disease; a gastrointestinal hypersensitivity reaction with severe nausea and vomiting in the first weeks; pancreatitis; and DRESS.
Who should avoid it
- People who have had a hypersensitivity reaction to azathioprine (contraindicated)
- Pregnant women being treated for rheumatoid arthritis (contraindicated)
- People with rheumatoid arthritis previously treated with alkylating agents (cyclophosphamide, chlorambucil, melphalan), who may have a prohibitive cancer risk
- People known to have homozygous TPMT or NUDT15 deficiency, for whom the label says to consider alternative therapy
Pregnancy & breastfeeding
Pregnancy: the Imuran label (Pregnancy Category D) says azathioprine can cause fetal harm, should not be given in pregnancy without carefully weighing risk against benefit, should be avoided in pregnancy whenever possible, and must not be used for rheumatoid arthritis in pregnant women. Low blood counts and immune problems have been reported in a few infants born to transplant recipients taking it. Women of childbearing age are advised to avoid becoming pregnant, and anyone who could become pregnant should discuss this with their doctor. Breastfeeding: the label says use while nursing is not recommended, because azathioprine or its metabolites pass into breast milk at low levels, and a decision should be made whether to stop nursing or stop the drug, taking into account its importance to the mother.
Interactions
Allopurinol blocks xanthine oxidase, one of the two main routes that inactivate azathioprine, so azathioprine levels and toxicity rise and can cause dangerous bone marrow suppression. The azathioprine and allopurinol labels say the azathioprine dose must be cut to about one-third to one-quarter of the usual dose, with further reduction or another treatment if TPMT activity is low. The two should be combined only when the prescriber managing azathioprine has planned it, with close blood count checks.
Febuxostat blocks the same enzyme as allopurinol, xanthine oxidase, and can raise azathioprine to toxic levels. The febuxostat (Uloric) label says it is contraindicated in people being treated with azathioprine, and the azathioprine label says using them together is not recommended. In a label study, febuxostat cut the clearance of mercaptopurine, azathioprine's active form, by about 83%, and an FDA review found 19 cases of serious blood count drops with febuxostat and azathioprine or mercaptopurine, 16 of them hospitalized. Tell every prescriber you take azathioprine before any gout treatment is chosen.
In people whose immune system is suppressed, live probiotic organisms can occasionally get into the blood. In a cluster of 6 children after stem cell transplant, the Lactobacillus found in their blood was genetically related to the probiotic they had taken; the report was not a study of azathioprine, and the authors said studies are needed on probiotic safety in immunocompromised patients. Ask your prescriber before taking any probiotic supplement, and report fever or chills promptly.
The label says ribavirin for hepatitis C, used with azathioprine, has been reported to cause severe pancytopenia, because it blocks an enzyme azathioprine needs and a toxic metabolite builds up. If both are used, blood counts are checked weekly in the first month, then twice monthly, then monthly.
The label says drugs that affect white cell production, including co-trimoxazole, may cause exaggerated leukopenia, especially after kidney transplant, and ACE inhibitors used for blood pressure have been reported to cause anemia and severe leukopenia with azathioprine. It also notes azathioprine may weaken warfarin. Your prescriber may check blood counts more often.
Documented interactions
Evidence-graded pair pages with sources, dosing notes, and timing guidance, a complement to the narrative section above.
Warnings (2)
+ allopurinol
criticalAllopurinol blocks one of the two enzymes that normally clear azathioprine from the body, so the same azathioprine dose becomes far more potent. The result is a well-documented and potentially fatal interaction.
+ febuxostat
criticalFebuxostat blocks xanthine oxidase, one of the main routes that inactivate azathioprine's active form, 6-mercaptopurine. In a label study it cut mercaptopurine clearance by 83.2% to 83.8% after a dose of azathioprine, which can lead to severe bone marrow suppression, and the Uloric label contraindicates the combination. An FDA review found 19 cases of serious blood count drops in people taking febuxostat with azathioprine or mercaptopurine, 16 of them hospitalized.
Choosing a product
What to look for on the label, and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Can I take allopurinol with azathioprine?⌄
Only if the prescriber managing your azathioprine has planned it. This page rates the pair critical: allopurinol blocks an enzyme that clears azathioprine, and the labels say the azathioprine dose must be cut to about one-third to one-quarter of usual, with close blood count checks. For febuxostat, another gout medicine that blocks the same enzyme, the febuxostat label says it is contraindicated with azathioprine and the azathioprine label says the combination is not recommended.
Can I take probiotics with azathioprine?⌄
This page rates live probiotic supplements a high-severity concern for people on immunosuppressants. The evidence is limited: one report describes 6 children after stem cell transplant whose bloodstream Lactobacillus was genetically related to the probiotic they had taken, and it was not a study of azathioprine. Ask your prescriber before taking any probiotic.
Why do I need a TPMT or NUDT15 test?⌄
People born with low activity of these enzymes build up active azathioprine and can develop severe, life-threatening low blood counts on usual doses. The label says to consider testing in people with severe bone marrow suppression, and that the test cannot replace regular blood counts. Ask your doctor whether you have been tested.
How often do I need blood tests on azathioprine?⌄
The label suggests a complete blood count with platelets weekly in the first month, twice monthly in the second and third months, then monthly or more often when doses or other medicines change. Your prescriber may also check liver tests.
How long does azathioprine take to work for rheumatoid arthritis?⌄
The label says a response usually takes 6 to 8 weeks, and an adequate trial is at least 12 weeks. Do not change your dose on your own while waiting; discuss progress with your prescriber.
References by claim
rheumatoid arthritis
Suarez-Almazor et al., 2000 · PubMed (2000) link
keeping Crohn's disease in remission (off-label)
Chande et al., 2015 · PMC (2015) link
Safety
Imuran (azathioprine) prescribing information · DailyMed (FDA label) link
Interaction: Allopurinol
Allopurinol tablets prescribing information · DailyMed (FDA label) link
Interaction: Probiotics (live bacteria or yeast supplements)
Gilliam et al., 2023 · PubMed (2023) link
Track Azathioprine with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora app.
Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.
